翔宇医疗(688626.SH)：第三季度净利润同比下降48.82%

Core Viewpoint - Xiangyu Medical (688626.SH) reported a year-on-year increase in operating revenue for Q3 2025, but experienced a significant decline in net profit attributable to shareholders [1] Financial Performance - Operating revenue for Q3 2025 reached 178 million yuan, representing a year-on-year increase of 5.46% [1] - Net profit attributable to shareholders was 8.59 million yuan, showing a year-on-year decrease of 48.82% [1] - Net profit attributable to shareholders after deducting non-recurring gains and losses was 6.91 million yuan, down 37.21% year-on-year [1]